Cancer Immunotherapy Biomarkers: Four Trends to Watch
Here are four trends to watch as researchers continue to make headway in the development of biomarkers for cancer immunotherapy.
Vaccine-Induced Specific Immune Response Offers an Avenue to Potentiate Responses to Immune Checkpoint Inhibitor Therapy
Cancer vaccine-based immunotherapy may help overcome the resistance of certain tumors to immune checkpoint inhibitors, while immune checkpoint inhibitors may enhance the efficacy of cancer vaccine therapies.